ALS, or Amyotrophic Lateral Sclerosis, is a serious, progressive illness that attacks the cells that control muscle movement. The result is an ever-worsening inability to control voluntary muscle movement. This leads to the loss of independence when patients are no longer able to speak, move, or even breathe without assistance. The emotional toll can be hard to bear. The need for treatment options is dire. There are currently no treatments that are able to stop or even slow down the degeneration of the brain and spinal cord. This motivates the search for alternative therapies within Regenerative Medicine Thailand that employ different cellular strategies. One of these primary strategies against ALS is the use of UC-MSCs.
Understanding the biological mechanism of cellular interventions for ALS
Understanding the biological mechanism of cellular interventions for ALS requires an analysis of their behavior in damaged neural environments, a key focus for Regenerative Medicine Thailand. When introduced into a biological system, UC-MSCs actively migrate toward areas of extensive neuroinflammation. This migration is due to specific gradients of chemokines released by stressed tissues, among other factors. Once they reach the desired neural location, the cells perform a highly developed form of paracrine signaling. They release a sophisticated secretome, which contains many neurotrophic factors. The aforementioned molecules create a protective atmosphere surrounding the stressed motor neurons, which prevents further apoptosis. Their secreted exosomes also contain microRNAs that influence the host cells’ gene expressions toward a repair mechanism. The other important mechanism of their action is extensive immunomodulation. The cells prompt a shift of pro-inflammatory microglia toward a neuroprotective phenotype. This modification of the local immune microenvironment decreases the oxidative stress that contributes to the accelerated death of neurons. In combination, this stabilizes the neural structure in the presence of the pestilence, i.e. the neural architecture degenerative disease.
Traditional ALS Treatments
In the past, treating the symptoms of ALS has been the primary focus. Unfortunately, reversing the neurological degeneration process has never really been prioritized or been possible. Even now, the modern pharmaceutical options extend a patient’s life by merely a handful of months. Riluzole and Edaravone, the two current treatments, promote the blocking of glutamate neurotransmission and free radical scavenging, respectively. While both of these treatments have gained clinical approval, they fail at motor neuron restoration and do not slow down the progressive degeneration of motor neurons. Riluzole and Edaravone fall short of patient needs and are not curative. The failure of traditional medicine to treat the root cause of the progressive condition exemplifies the tremendous thought and care gap in treating neurological degeneration. The combination of the failure of traditional medicine to be curative and the failure of traditional therapies to promote significant improvement on quality-of-life demand novel approaches to the care of patients. Without reliance on new care modalities like UC-MSCs championed by Regenerative Medicine Thailand, traditional medicine forces these ALS patients into an inhumane slow death.
Cellular Integration Justification
The focus of ALS research is leaning towards innovative biological treatments, given the ability of these therapies to target multiple pathways of a disease. Compared to conventional medications, UC-MSCs are a much more totalizing approach. These cells are able to regenerate without the ethical concerns of other cells sources. Even more, they are able to evade the patient’s immune response, avoiding the need for immunosuppressive treatments. Their use is justified by their ability to target to the dynamic microenvironment. In contrast to static chemical drugs, UC-MSCs are able to communicate with the damaged or dying cells by adjusting their support. They provide the supportive environment to the spinal cord that is needed in order for the dying neurons to survive. Given their immune evasive properties to protect the dying neurons, they have the ability to elicit a neuroprotective environment directly to the Spinal Cord. Establishing these technologies in Regenerative Medicine Thailand aims to improve the internal environment that protects dying neurons from immune assaults.
Figure 1: Traditional ALS Treatments and Cellular Integration Justification with UC-MSCs
Trends and Future in Thailand
Southeast Asia has become a vital zone for clinical advancement as a result of the relocation of the biomedical innovation market. Slow, but favorable changes in the Thai government pave the way for dynamic growth in Regenerative Medicine Thailand. Highly prestigious research hospitals and sophisticated laboratories equip Thailand with the tools and research infrastructures for advanced therapeutics. This, combined with the country’s favorable government policies, draws researchers and clinical biologists from around the globe. This region is one of the most affordable locations for clinical trials, and boasts a diverse profile of potential research subjects. The country also has a high level of quality control when it comes to research and testing, especially in cell-based assays. As researchers begin to enhance the precision of the cell-based assays and the dosage of the assays, the field of Regenerative Medicine Thailand is ready to make breakthroughs in ALS therapeutics using UC-MSCs. The dedication to research and the infrastructure of the medical institutions will create the advanced therapeutics of the future.
The time for novel approaches to treat neurodegenerative disorders like ALS has come. The use of UC-MSCs offers an active biological defense against neurodegenerative pathology. These cells provide neurotrophic support while combating toxic neuroinflammation. The use of these MSCs presents a viable substitute to the previously inadequate methods. The development of these cellular therapies represents a monumental advancement of the modern healthcare system. The rapid advancement of Regenerative Medicine Thailand provides the necessary work environment for the development of an effective treatment within their healthcare system. With the addition of modern cellular technologies, there remains great optimism to restore therapy for patients diagnosed with ALS, while extending their lifespan.